Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Vision Loss in Patients With Age-Related Neovascular Macular Degeneration by Intravitreal Injection of Bevacizumab and Ranibizumab in a Typical Outpatient Setting

NCT00559715 is registered in ClinicalTrials.gov with Klinikum Bremen-Mitte, gGmbH as lead sponsor.

NCT NCT00559715
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00559715 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Vision Loss in Patients With Age-Related Neovascular Macular Degeneration by Intravitreal Injection of Bevacizumab and Ranibizumab in a Typical Outpatient Setting
Lead sponsor
Klinikum Bremen-Mitte, gGmbH
Phase
Phase 3
Overall status
Unknown status
Start date
August 31, 2008
Completion date
August 31, 2010
Enrollment
366 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related neovascular macular degeneration